Document is current
Any future updates will be listed below
-
Authors
Elo, Petri
Li, Xiang-Guo
Liljenbäck, Heidi
Gardberg, Maria
Moisio, Olli
Miner, Maxwell
Virta, Jenni
Saraste, Antti
Srinivasarao, Madduri
Pugh, Michael
Low, Philip S.
Knuuti, Juhani
Jalkanen, Sirpa
Airas, Laura
Lu, Yingjuan June
Roivainen, Anne https://orcid.org/0000-0002-4006-7977
-
Funding
Funding for this research was provided by:
Jane ja Aatos Erkon Säätiö
State Research Funding of Turku University Hospital (ERVA#13303)
Sigrid Juséliuksen Säätiö
Instrumentariumin Tiedesäätiö
Alfred Kordelinin Säätiö
Orionin Tutkimussäätiö
Drug Research Doctoral Programme of the University of Turku Graduate School
- License Information
-
More Information
Article History
Received: 12 August 2020
Accepted: 5 January 2021
First Online: 20 January 2021
Ethics approval and consent to participate
: All animal experiments were approved by the National Animal Experiment Board of Finland and the Regional State Administrative Agency for Southern Finland (license number: ESAVI/2979/2018) and conducted in accordance with the relevant European Union directive. The study of archival human tissues was approved by the Auria Biobank Scientific Steering Committee (decision AB19-2623). According to the Finnish Biobank Act (688/2012), separate informed consent from individual patients is not needed.
: Not applicable.
: Michael Pugh and Yingjuan June Lu are full-time employees of Novartis. All other authors declare no potential conflicts of interest.
